A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer
Clinical trial NCT06396091 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06396091
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-24
- Primary completion
- 2026-07-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.